Diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
It is very uncertain whether probiotics changes any diarrhoea compared with other active treatment (very low certainty).
1 finding from 1 review
Quality of life ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Grade ≥ 3 diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
Probiotics may leads to lower severity of diarrhoea: grade 3 or higher compared with other active treatment (low certainty).
1 finding from 1 review
Time to rescue medication ‐ not measured · participants with cancer treated with radiotherapy (with or without chemotherapy)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Requiring rescue medication for diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
It is very uncertain whether probiotics changes requiring rescue medication for diarrhoea compared with other active treatment (very low certainty).
1 finding from 1 review
Adverse events · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
All‐cause mortality · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Intervention not reported
Overall quality of life change score ‐ up to 12 weeks' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall social functioning change ‐ up to 12 weeks' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall social functioning change ‐ 6 months' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall quality of life change score ‐ 6 months' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall anxiety change ‐ Up to 12 weeks' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall emotional well‐being/mental health change ‐ up to 12 weeks' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall fatigue change ‐ Up to 12 weeks' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall fatigue change ‐ More than 12 weeks less than 6 months' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall pain · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall sexuality change ‐ 6 months' · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Intervention not reported
Overall sleep disturbance · Cancer survivors who have completed active cancer treatment
1 finding from 1 review
Major bleeding · patients with active cancer with venous thromboembolism
Direct oral anticoagulant secondary prophylaxis showed no clear difference in major bleeding compared with vitamin K antagonist secondary prophylaxis (low certainty).
1 finding from 1 review
Minor bleeding · patients with active cancer with venous thromboembolism
Direct oral anticoagulant secondary prophylaxis showed no clear difference in minor bleeding compared with vitamin K antagonist secondary prophylaxis (low certainty).
1 finding from 1 review